Literature DB >> 18780370

Perlman syndrome: report, prenatal findings and review.

Jean-Luc Alessandri1, Fabrice Cuillier, Duksha Ramful, Sandrine Ernould, Stéphanie Robin, Stefan de Napoli-Cocci, Jean-Pierre Rivière, Sylvie Rossignol.   

Abstract

Perlman syndrome is a rare overgrowth syndrome characterized by polyhydramnios with neonatal macrosomia, nephromegaly, distinctive facial appearance, renal dysplasia, nephro-blastomatosis, and predisposition to Wilms tumor (WT). We report on a newborn with prenatal sonographic signs of Perlman syndrome, large fetal ascites, nephromegaly and macrosomia. The clinical course was marked by neonatal distress, renal failure and refractory hypoxemia leading to death at 2 days of life. Renal histologic examination showed bilateral nephroblastomatosis. Genetic or epigenetic alterations of the 11p15 region (involved in the BWS), including mutation of the CDKN1C gene were excluded. No mutation of the GPC3 gene was identified. We review the 28 patients who have been reported with Perlman syndrome. The prognosis of Perlman syndrome is poor with a high neonatal mortality rate. Among the infants who survived beyond the neonatal period, 64% developed a WT and all had a developmental delay. Fetal macrosomia, ascites and polyhydramnios are frequent manifestations. Clinical overlaps with other overgrowth syndromes particularly Beckwith-Wiedemann syndrome and Simpson-Golabi-Behmel syndrome have been emphasized. Perlman syndrome is considered as an autosomal recessive condition. We review 19 patients from seven sibships with parental consanguinity in two families only. The other cases were sporadic. The 28 reported patients had only 10 unaffected sibs. The low percentage of consanguinity among parents is also puzzling for a rare recessive condition. The molecular basis of Perlman syndrome is unknown. (Epi)genetic anomalies of 11p15 and mutations in GPC3 were not studied in most of the previous reports. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18780370     DOI: 10.1002/ajmg.a.32391

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  14 in total

1.  Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.

Authors:  Dewi Astuti; Mark R Morris; Wendy N Cooper; Raymond H J Staals; Naomi C Wake; Graham A Fews; Harmeet Gill; Dean Gentle; Salwati Shuib; Christopher J Ricketts; Trevor Cole; Anthonie J van Essen; Richard A van Lingen; Giovanni Neri; John M Opitz; Patrick Rump; Irene Stolte-Dijkstra; Ferenc Müller; Ger J M Pruijn; Farida Latif; Eamonn R Maher
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

2.  Refractory arterial hypertension and renal failure combined with cerebral seizures and pancytopenia in a 5-year-old girl with bilateral nephromegaly: Answers.

Authors:  Patrick Hundsdoerfer; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2015-08-11       Impact factor: 3.714

Review 3.  Approach to the Diagnosis of Overgrowth Syndromes.

Authors:  Mohnish Suri
Journal:  Indian J Pediatr       Date:  2015-12-18       Impact factor: 1.967

Review 4.  Overgrowth Syndromes.

Authors:  Andrew C Edmondson; Jennifer M Kalish
Journal:  J Pediatr Genet       Date:  2015-09-25

5.  Two Consecutive Pregnancies with Simpson-Golabi-Behmel Syndrome Type 1: Case Report and Review of Published Prenatal Cases.

Authors:  Konstantin Ridnõi; Elvira Kurvinen; Sander Pajusalu; Tiia Reimand; Katrin Õunap
Journal:  Mol Syndromol       Date:  2018-06-08

6.  Homozygous deletion of DIS3L2 exon 9 due to non-allelic homologous recombination between LINE-1s in a Japanese patient with Perlman syndrome.

Authors:  Ken Higashimoto; Toshiyuki Maeda; Junichiro Okada; Yasufumi Ohtsuka; Kensaku Sasaki; Akiko Hirose; Makoto Nomiyama; Toshimitsu Takayanagi; Ryuji Fukuzawa; Hitomi Yatsuki; Kayoko Koide; Kenichi Nishioka; Keiichiro Joh; Yoriko Watanabe; Koh-ichiro Yoshiura; Hidenobu Soejima
Journal:  Eur J Hum Genet       Date:  2013-03-13       Impact factor: 4.246

Review 7.  Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma.

Authors:  Jennifer M Kalish; Leslie Doros; Lee J Helman; Raoul C Hennekam; Roland P Kuiper; Saskia M Maas; Eamonn R Maher; Kim E Nichols; Sharon E Plon; Christopher C Porter; Surya Rednam; Kris Ann P Schultz; Lisa J States; Gail E Tomlinson; Kristin Zelley; Todd E Druley
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

Review 8.  Overgrowth syndromes - clinical and molecular aspects and tumour risk.

Authors:  Frédéric Brioude; Annick Toutain; Eloise Giabicani; Edouard Cottereau; Valérie Cormier-Daire; Irene Netchine
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

9.  Chromosome 4q28.3q32.3 duplication in a patient with lymphatic malformations, craniosynostosis, and dysmorphic features.

Authors:  Eric S Traub; Sarah E Sheppard; Yoav Dori; Katelyn D Burns; Elaine H Zackai; Stephanie M Ware; Benjamin J Landis; Dong Li; David D Weaver
Journal:  Clin Dysmorphol       Date:  2021-04-01       Impact factor: 0.884

10.  Loss of Dis3l2 partially phenocopies Perlman syndrome in mice and results in up-regulation of Igf2 in nephron progenitor cells.

Authors:  Ryan W Hunter; Yangjian Liu; Hema Manjunath; Asha Acharya; Benjamin T Jones; He Zhang; Beibei Chen; Harini Ramalingam; Robert E Hammer; Yang Xie; James A Richardson; Dinesh Rakheja; Thomas J Carroll; Joshua T Mendell
Journal:  Genes Dev       Date:  2018-06-27       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.